Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HIFU Prostate Services (HPS) is a leading healthcare service provider specializing in non-invasive prostate cancer treatments using High-Intensity Focused Ultrasound (HIFU) technology. Headquartered in Charlotte, North Carolina, the company operates a mobile service model, providing hospitals and physicians with access to the Sonablate HIFU system and expert technicians on a per-procedure basis. This turnkey solution allows medical facilities to offer advanced focal therapy for localized prostate cancer without the need for significant capital investment in equipment. HPS has treated over 4,000 patients across a network of nearly 100 hospitals in the United States. In 2024, the company expanded its market leadership by acquiring the HIFU assets of Vituro Health, further consolidating its position as the largest mobile HIFU provider in the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mobile HIFU.